Search for other papers by The Working Group for Renaming Diabetes Insipidus in
Google Scholar
PubMed
Japan Endocrine Society
Search for other papers by Hiroshi Arima in
Google Scholar
PubMed
European Society for Pediatric Endocrinology
Search for other papers by Timothy Cheetham in
Google Scholar
PubMed
European Society of Endocrinology
Search for other papers by Mirjam Christ-Crain in
Google Scholar
PubMed
Search for other papers by Deborah Cooper in
Google Scholar
PubMed
Wellcome-MRC Institute of Metabolic Science, University of Cambridge & Addenbrooke’s Hospital, Cambridge Biomedical Campus, Cambridge, UK
Search for other papers by Mark Gurnell in
Google Scholar
PubMed
Brazilian Society of Endocrinology and Metabolism
Search for other papers by Juliana B Drummond in
Google Scholar
PubMed
Society for Endocrinology
Search for other papers by Miles Levy in
Google Scholar
PubMed
Endocrine Society of Australia
Search for other papers by Ann I McCormack in
Google Scholar
PubMed
Endocrine Society
Search for other papers by Joseph Verbalis in
Google Scholar
PubMed
Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, UK
Search for other papers by John Newell-Price in
Google Scholar
PubMed
Pituitary Society
Search for other papers by John A H Wass in
Google Scholar
PubMed
processes, leading to treatment errors and consequent adverse outcomes for patients. This last reason represents the major impetus to change the name of diabetes insipidus at this time. Historical context Before explaining the rationale for the name
Department of Neurosurgery, 900TH Hospital of the Joint Logistics Support Force, Fuzhou, Fujian, China
Search for other papers by Liang Xue in
Google Scholar
PubMed
Search for other papers by Jianwu Wu in
Google Scholar
PubMed
Search for other papers by Jie Chen in
Google Scholar
PubMed
Search for other papers by Yongkai Yang in
Google Scholar
PubMed
Introduction Most pituitary adenomas (PAs) can be treated surgically using a transnasal approach; experienced clinicians can perform this surgical method effectively, ensuring safety for patients. However, diabetes insipidus (DI) is a common
Search for other papers by Beril Erdem in
Google Scholar
PubMed
Search for other papers by Angela Schulz in
Google Scholar
PubMed
Search for other papers by Emel Saglar in
Google Scholar
PubMed
Search for other papers by Ferhat Deniz in
Google Scholar
PubMed
Search for other papers by Torsten Schöneberg in
Google Scholar
PubMed
Search for other papers by Hatice Mergen in
Google Scholar
PubMed
following an osmotic gradient ( 1 , 2 ). Disruption of the renal AVPR2/AQP2 pathway can cause nephrogenic diabetes insipidus (NDI) characterized by the inability to concentrate urine ( 3 , 4 ). Patients have abnormally diluted and large volumes of urine
Search for other papers by S E Baldeweg in
Google Scholar
PubMed
Search for other papers by S Ball in
Google Scholar
PubMed
Search for other papers by A Brooke in
Google Scholar
PubMed
Search for other papers by H K Gleeson in
Google Scholar
PubMed
Search for other papers by M J Levy in
Google Scholar
PubMed
Search for other papers by M Prentice in
Google Scholar
PubMed
Search for other papers by J Wass in
Google Scholar
PubMed
Search for other papers by the Society for Endocrinology Clinical Committee in
Google Scholar
PubMed
Introduction Cranial diabetes insipidus (CDI) is due to the relative or absolute lack of the posterior pituitary hormone vasopressin (AVP), also known as anti-diuretic hormone (ADH). AVP is the major determinant of renal water resorption. AVP
Search for other papers by M de Fost in
Google Scholar
PubMed
Search for other papers by S M Oussaada in
Google Scholar
PubMed
Search for other papers by E Endert in
Google Scholar
PubMed
Search for other papers by G E Linthorst in
Google Scholar
PubMed
Search for other papers by M J Serlie in
Google Scholar
PubMed
Search for other papers by M R Soeters in
Google Scholar
PubMed
Search for other papers by J H DeVries in
Google Scholar
PubMed
Search for other papers by P H Bisschop in
Google Scholar
PubMed
Search for other papers by E Fliers in
Google Scholar
PubMed
Introduction Polyuria (diuresis >3 l/day) in the absence of common causes, such as hypercalcemia, hyperglycemia, or relief of urinary tract obstruction, can be caused by diabetes insipidus (DI) or primary polydipsia (PP, also referred to as
Department of Clinical Research, University of Basel, Basel, Switzerland
Search for other papers by Laura Potasso in
Google Scholar
PubMed
Search for other papers by Julie Refardt in
Google Scholar
PubMed
Search for other papers by Irina Chifu in
Google Scholar
PubMed
Central Laboratory, University Hospital Wuerzburg, Wuerzburg, Germany
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Leipzig University Medical Center, IFB Adiposity Diseases, Leipzig, Germany
Search for other papers by Wiebke Kristin Fenske in
Google Scholar
PubMed
Department of Clinical Research, University of Basel, Basel, Switzerland
Search for other papers by Mirjam Christ-Crain in
Google Scholar
PubMed
Introduction The hypertonic saline infusion test with continuous infusion of 3% NaCl has recently been put forward as a new test for the diagnosis of diabetes insipidus (DI) ( 1 ). For other indications such as hemorrhagic and septic shock
Department of Clinical Research, University of Basel, Basel, Switzerland
Search for other papers by Julie Refardt in
Google Scholar
PubMed
Department of Clinical Research, University of Basel, Basel, Switzerland
Search for other papers by Clara Odilia Sailer in
Google Scholar
PubMed
Department of Clinical Research, University of Basel, Basel, Switzerland
Search for other papers by Bettina Winzeler in
Google Scholar
PubMed
Department of Clinical Research, University of Basel, Basel, Switzerland
Search for other papers by Matthias Johannes Betz in
Google Scholar
PubMed
Search for other papers by Irina Chifu in
Google Scholar
PubMed
Department of Clinical Research, University of Basel, Basel, Switzerland
Search for other papers by Ingeborg Schnyder in
Google Scholar
PubMed
Central Laboratory, University Hospital Würzburg, Würzburg, Germany
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Leipzig University Medical Center, IFB Adiposity Diseases, Leipzig, Germany
Search for other papers by Wiebke Fenske in
Google Scholar
PubMed
Department of Clinical Research, University of Basel, Basel, Switzerland
Search for other papers by Mirjam Christ-Crain in
Google Scholar
PubMed
Search for other papers by for the CODDI-Investigators in
Google Scholar
PubMed
Introduction Polyuria polydipsia syndrome is a common problem in clinical practice with the two main entities being primary polydipsia and central diabetes insipidus ( 1 ). While the pathomechanism of central diabetes insipidus is well known
Search for other papers by Aida Javanbakht in
Google Scholar
PubMed
Search for other papers by Massimo D’Apuzzo in
Google Scholar
PubMed
Search for other papers by Behnam Badie in
Google Scholar
PubMed
Search for other papers by Behrouz Salehian in
Google Scholar
PubMed
adenomas, metastatic tumors, when detected, are more likely to be located in the posterior pituitary. This likely accounts for diabetes insipidus (DI) being more common in patients with Pit Met than patients with other pituitary pathology. The exact
Search for other papers by Dan Liang in
Google Scholar
PubMed
Search for other papers by Han Chen in
Google Scholar
PubMed
Search for other papers by Li-Yong Zhong in
Google Scholar
PubMed
diabetes insipidus (CDI): presentation of polyuria (>50 mL/kg d or 3.5 L/day) with elevated plasma osmolality (300 mOsm/kg H 2 O) and decreased urine osmotic pressure (<600 mOsmol/L) mOsm/kg H 2 O) and negative urine glucose. Impairment to hypothalamic
Department of Medicine, Division of Endocrinology and Centre for Endocrine Tumors, Leiden University Medical Centre, Leiden, The Netherlands
Department of Neurosurgery, University Neurosurgical Centre Holland (UNCH), Leiden University Medical Centre, Haaglanden Medical Centre and Haga Teaching Hospitals, Leiden and The Hague, The Netherlands
Search for other papers by Amir H Zamanipoor Najafabadi in
Google Scholar
PubMed
Search for other papers by Merel van der Meulen in
Google Scholar
PubMed
Search for other papers by Ana Luisa Priego Zurita in
Google Scholar
PubMed
Search for other papers by S Faisal Ahmed in
Google Scholar
PubMed
Search for other papers by Wouter R van Furth in
Google Scholar
PubMed
Search for other papers by Evangelia Charmandari in
Google Scholar
PubMed
Search for other papers by Olaf Hiort in
Google Scholar
PubMed
Search for other papers by Alberto M Pereira in
Google Scholar
PubMed
Search for other papers by Mehul Dattani in
Google Scholar
PubMed
Search for other papers by Diana Vitali in
Google Scholar
PubMed
Search for other papers by Johan P de Graaf in
Google Scholar
PubMed
Search for other papers by Nienke R Biermasz in
Google Scholar
PubMed
% (95% CI: 0–17). Transient diabetes insipidus was reported in 12% (95% CI: 6–21) and permanent diabetes insipidus in 4% (95% CI: 3–6). SIADH occurred in 6% (95% CI: 3–19). Mild epistaxis was reported in 3% (95% CI: 1–4%) and severe epistaxis in 2% (95